Valion Bio (VBIO) Interest Expenses (2021 - 2024)

Valion Bio (VBIO) posted Interest Expenses of $60000.0 for Q2 2024, down 73.09% on a QoQ basis from $223000.0 in Q2 2021.

Analysis

Valion Bio (VBIO) Interest Expenses (2021 - 2024) Analysis & Trends

Valion Bio has reported Interest Expenses for 2 years, with the latest figure at $60000.0 in Q2 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Amgen	206.44 Bn	192.45 Bn	7.24 Bn	673.00 Mn
2	Gilead Sciences	179.97 Bn	176.79 Bn	6.22 Bn	247.00 Mn
3	Vertex Pharmaceuticals	130.57 Bn	122.72 Bn	2.84 Bn	-
4	Regeneron Pharmaceuticals	81.63 Bn	73.63 Bn	3.93 Bn	11.00 Mn
5	Argenx Se	60.34 Bn	55.16 Bn	1.37 Bn	-1.00 Mn
6	Moderna	54.37 Bn	49.23 Bn	52.00 Mn	-
7	Alnylam Pharmaceuticals	33.07 Bn	29.76 Bn	992.69 Mn	82.05 Mn
8	Biogen	31.84 Bn	30.55 Bn	1.96 Bn	-
9	Roivant Sciences	29.49 Bn	29.49 Bn	1.16 Mn	-
10	Valion Bio	298,792.01	-1.90 Mn	-45,000.00	-

Historic Data

Download Data